General Information of Drug (ID: DM79XFF)

Drug Name
XENO-Skin
Indication
Disease Entry ICD 11 Status REF
Burns N.A. Phase 1/2 [1]
Drug Type
Cell therapy
Cross-matching ID
TTD ID
D0ARB7

References

1 ClinicalTrials.gov (NCT03695939) An Open-label Phase 1/2 Study to Evaluate the Safety, Tolerability, and Efficacy of realSKIN? (Skin Xenotransplant) for Complete Closure of Severe and Extensive Deep-Partial and Full-Thickness Burn Wounds. U.S.National Institutes of Health.